Product
YKP3089
1 clinical trial
1 indication
Indication
Partial EpilepsyClinical trial
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresStatus: Completed, Estimated PCD: 2021-03-31